Ursolic Acid

Ursolic acid is a naturally occurring pentacyclic triterpenoid concentrated in the protective waxy cuticle of apples and present in many culinary and medicinal plants, including rosemary, thyme, basil, holy basil, and hawthorn. Interest in it as a muscle compound began with a computational screen: Kunkel and colleagues compared the mRNA signatures of atrophying human muscle (from fasting and spinal cord injury) against the Connectivity Map and found that ursolic acid produced a gene-expression pattern opposite to atrophy. In mice, ursolic acid reduced fasting- and denervation-induced muscle loss and stimulated hypertrophy, largely by enhancing insulin/IGF-I signaling and suppressing the atrophy-associated genes atrogin-1 (MAFbx) and MuRF1 ^[1].

A follow-up study in mice fed a high-fat diet showed that dietary ursolic acid increased skeletal muscle mass and grip strength while also raising brown adipose tissue and energy expenditure. The same animals had less diet-induced obesity, lower fasting glucose and insulin, reduced glucose intolerance, and less hepatic steatosis, an effect the authors linked to increased Akt activity in muscle and browning of fat ^[2]. Mechanistically, the muscle effects are attributed to ursolic acid enhancing ligand-dependent autophosphorylation of the IGF-I and insulin receptors, which propagates through PI3K/Akt to promote protein synthesis and glucose uptake while restraining FoxO-driven proteolysis ^[1][2].

Human evidence is limited and inconsistent. A small controlled study in resistance-trained men reported that ursolic acid during eight weeks of training raised serum irisin and IGF-1, reduced body fat percentage, and increased some measures of maximal strength, without changing lean mass ^[3]. Another small trial in low-activity men found ursolic acid raised irisin and lowered the inflammatory markers CRP, IL-6, and TNF-alpha during high-intensity resistance training ^[5]. In contrast, a placebo-controlled pilot in healthy men found no change in circulating TNF-alpha, IL-6, or IL-10 cytokines after eight weeks of supplementation with training ^[6]. These trials are small, short, and heterogeneous in design, so conclusions about body composition and performance in people remain tentative.

Beyond muscle, ursolic acid has a broad preclinical pharmacology. It suppresses NF-kB, AP-1, and NF-AT signaling and inhibits ERK and JNK phosphorylation in immune cells, which underlies much of its anti-inflammatory activity ^[4]. A systematic review and meta-analysis of animal studies concluded that ursolic acid consistently lowers inflammatory and oxidative markers across disease models, while noting the low quality and preclinical nature of the underlying data ^[7]. A recurring practical limitation across all of this work is pharmacokinetics: ursolic acid is a Biopharmaceutics Classification System class IV molecule with poor aqueous solubility and low intestinal permeability, so oral bioavailability is low and human exposure at typical supplement doses is uncertain ^[7].

ursolic acid is a normal part of the diet (you eat it every time you eat an apple with the peel), and it has a long history of food-level exposure with no clear signal of harm. supplement trials at ~400 mg/day for 8 weeks reported no notable adverse effects, but these were small and short, so the human safety database is genuinely thin. high concentrations in cell studies can be cytotoxic (that's partly why it's studied in cancer), but those exposures don't reflect oral dosing. theoretical cautions: it affects glucose/insulin signaling, so if you're on diabetes medication, watch for additive effects; and it modulates drug-handling nuclear receptors (PXR), so interactions with medications are plausible though unquantified in people. pregnancy and breastfeeding: not studied, so skip it. as always with poorly absorbed triterpenoids, the practical risk is mostly that it does less than hoped, not that it harms you.